Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
92.73
-5.34 (-5.45%)
At close: Feb 27, 2026, 4:00 PM EST
92.66
-0.07 (-0.08%)
After-hours: Feb 27, 2026, 7:32 PM EST
Rhythm Pharmaceuticals Market Cap
Rhythm Pharmaceuticals has a market cap or net worth of $6.23 billion as of February 27, 2026. Its market cap has increased by 76.11% in one year.
Market Cap
6.23B
Enterprise Value
5.96B
1-Year Change
76.11%
Ranking
Category
Stock Price
$92.73
Market Cap Chart
Since October 5, 2017, Rhythm Pharmaceuticals's market cap has increased from $813.90M to $6.23B, an increase of 665.69%. That is a compound annual growth rate of 27.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 6.54B | -8.38% |
| Dec 31, 2025 | 7.14B | 107.63% |
| Dec 31, 2024 | 3.44B | 26.64% |
| Dec 29, 2023 | 2.72B | 65.56% |
| Dec 30, 2022 | 1.64B | 227.07% |
| Dec 31, 2021 | 501.70M | -61.82% |
| Dec 31, 2020 | 1.31B | 30.30% |
| Dec 31, 2019 | 1.01B | 9.04% |
| Dec 31, 2018 | 925.00M | 16.66% |
| Dec 29, 2017 | 792.90M | -2.58% |
| Oct 5, 2017 | 813.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 7.38B |
| Belite Bio | 7.13B |
| Arcellx | 6.66B |
| Cogent Biosciences | 6.17B |
| Caris Life Sciences | 6.01B |
| CRISPR Therapeutics AG | 5.84B |
| Protagonist Therapeutics | 5.78B |
| Mirum Pharmaceuticals | 5.69B |